Thierry G.
- Country
- Belgium
- Department
- Gastroenterology/HepatoPancreatology/Digestive Oncology
Research Overview
- HepaStem Long-Term Safety Registry – Registry for Patients who have been administered HepaStem
- Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital Mortality
- Phase I/II Evaluation of QEL-001, Autologous CAR T Regulatory Cells, for Safety in HLA-A2 Mismatch Liver Transplant Rejection Prevention
Data & Insights
Has run more than one trial at 12 of 57 partner sites.
Specializations
Liver Failure Management
Specializes in treating patients with acute-on-chronic liver failure (ACLF), particularly focusing on severe cases with high mortality risk. Investigates therapeutic approaches combining standard medical treatment with specialized interventions for improved patient survival.
- ACLF Grade Management
- Critical Care Hepatology
- Hospital Mortality Risk Assessment
Expertise in managing various grades of ACLF, from ACLF-1b through ACLF-3a.
Transplant Medicine
Focuses on advancing liver transplant rejection prevention through innovative therapeutic approaches. Evaluates novel treatments for transplant recipients, particularly in A2-mismatch liver transplant cases.
- Transplant Immunology
- Rejection Prevention Protocols
- Post-Transplant Care
Specializes in developing and assessing new therapeutic options for transplant patients.
Cell-Based Therapies
Conducts research in stem cell therapeutics for liver disorders, with particular emphasis on long-term treatment outcomes. Focuses on innovative cellular therapies for various hepatic conditions.
- Urea Cycle Disorders
- Crigler-Najjar Syndrome
- Fibroinflammatory Liver Diseases
Evaluates the safety and efficacy of cellular therapeutic approaches in rare liver disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.